R. Alexanian

1.0k citations
12 papers · 195 indexed · h-index 6
Topics
Multiple Myeloma Research and Treatments (10 papers)Cancer Treatment and Pharmacology (7 papers)Cancer therapeutics and mechanisms (2 papers)
Partner nations
United StatesMexico

In The Last Decade

R. Alexanian

11 papers receiving 187 citations

Peers

R. Alexanian
Comparison fields: 5 of 30
  • Hematology 177
  • Molecular Biology 125
  • Oncology 96
  • Genetics 12
  • Surgery 10
Replace A. Keith Stewart with:
A. Keith Stewart United States
Maria Soroka‐Wojtaszko Poland
Petra H.M. Westveer Netherlands
Eli Gabayan United States
Joan Bladé Spain
S Triolo Italy
Ana-Isabel Teruel Spain
Dixil Francis United States
Nola Kennedy Australia
C. Hulin France
R. Alexanian relative to A. Keith Stewart United States A. Keith Stewart's profile →
Citations per field
00.5×1.7×
A. Keith Stewart · 1×
Citations per year

Countries citing papers authored by R. Alexanian

Since Specialization
Citations

This map shows the geographic impact of R. Alexanian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Alexanian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Alexanian more than expected).

Fields of papers citing papers by R. Alexanian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Alexanian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Alexanian. The network helps show where R. Alexanian may publish in the future.

Co-authorship network of co-authors of R. Alexanian

This figure shows the co-authorship network connecting the top 25 collaborators of R. Alexanian. A scholar is included among the top collaborators of R. Alexanian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Alexanian. R. Alexanian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
#WorkIndexed citations
1 1
2 12
3 1
4
Thalidombde with dexamethasone for resistant multiple myeloma
9
5 1
6
[Multiple myeloma and chronic lymphocytic leukemia].
1
7 17
8 94
9 9
10 47
11 3
12
Effect of splenectomy on bone marrow cellularity in the dog.
0

About R. Alexanian

R. Alexanian is a scholar working on Hematology, Oncology and Hepatology, having authored 12 papers that have together received 195 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (10 papers), Cancer Treatment and Pharmacology (7 papers) and Cancer therapeutics and mechanisms (2 papers). The work is most often cited by research in Hematology (177 citations), Oncology (96 citations) and Molecular Biology (125 citations). R. Alexanian has collaborated with scholars based in United States and Mexico. Frequent co-authors include Meletios Α. Dimopoulos, Kay Delasalle, R. Champlin, J. P. Hester, Bart Barlogie, John Crowley, Joth Jacobson, Maria Gavino, Donna M. Weber and Damien C. Weber. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026